In Vitro and In Vivo Evaluation of Novel Anticancer Agents in Triple Negative Breast Cancer Models

Triple negative breast cancer (TNBC) is subtype of breast disease devoid of the estrogen, progesterone, and Her2/neu receptors which are targets for pharmacological intervention. There is a need for novel anti-breast cancer agents that target TNBC. Therefore, novel isochalcone DJ52 was evaluated usi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Johnson, KiTani Parker, Johnson, Duane E., Stoute, Diana, Burow, Matthew E., Rhodes, Lyndsay V., Gray, Marian, Carriere, Patrick, Tilghman, Syreeta L., McLachlan, John A., Ochieng, Josiah
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3628744/
https://ncbi.nlm.nih.gov/pubmed/23395947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1353/hpu.2013.0047
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados